Magnesium for leg cramps: what studies found

Results for magnesium for leg cramps in adults and during pregnancy, study conditions and dose limitations.

Key points

  • In adults aged 50–85 with frequent leg cramps, magnesium did not show a convincing reduction in their number over four weeks compared with placebo. Based on this study, a noticeable reduction in cramps should not be expected for this group. [1] See the evidence 1
  • In one small study of pregnant participants with cramps, a reduction in frequency by at least half was reported more often with bisglycinate than placebo over four weeks. Other studies gave mixed results, so discuss use during pregnancy with a professional. [2] [3] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

Leg cramps have been studied in different groups. Results differed between older adults and during pregnancy.

Magnesium for leg cramps

Why these conclusions

What studies found

A study of adults aged 50–85 with leg cramps at least twice weekly compared 250 mg elemental magnesium daily with placebo for four weeks. No convincing difference in weekly cramp count was found; cramps at any time of day were counted. The salt’s name in the article is ambiguous. Confidence in the result is low: 2 out of 4. Other types of cramps were not assessed by this result. [1]

In a small four-week study, healthy pregnant participants at 14–34 weeks with leg cramps at least twice weekly received bisglycinate or placebo. A reduction in frequency by at least half was reported more often in the supplement group; other studies are conflicting. The study gave 300 mg elemental magnesium daily as 100 mg three times daily. This is the studied amount, not a self-dosing regimen. Confidence is very low: 1 out of 4. [2] [3]

No convincing difference in the number of leg cramps per week was found. Cramps at any time of day were counted.

ParameterData
ResultNo convincing difference in the number of leg cramps per week was found. Cramps at any time of day were counted.
ParticipantsAdults aged 50–85 with leg cramps at least twice weekly; cramps at any time of day counted
Formthe magnesium salt is described ambiguously in the article
Dose250 mg elemental magnesium daily according to the article; the exact salt remains disputed
Dose basis250 mg elemental magnesium daily according to the article; the exact salt remains disputed
ComparatorPlacebo
Duration4 weeks of treatment
Confidence2/4: Risk of bias: Attrition, incomplete original plans or limited assessment of individual trials’ risk.; Consistency: No serious unexplained heterogeneity was found for the specific outcome. There is no additional reduction in confidence on this basis.; Applicability to the specified group: The conclusion is limited to the specified group, dose and outcome. There is no additional reduction in confidence on this basis.; Precision: A small sample and a wide or unreported interval leave substantial uncertainty.; Possible publication bias: No specific reason for a separate reduction; unpublished data cannot be ruled out. There is no additional reduction in confidence on this basis.
Evidence base1 publication described
Sources[1]

In a small study of pregnant participants with cramps, a reduction in frequency by at least half was reported more often; findings of other studies are mixed, so the result calls for caution.

ParameterData
ResultIn a small study of pregnant participants with cramps, a reduction in frequency by at least half was reported more often; findings of other studies are mixed, so the result calls for caution.
Participants86 healthy pregnant participants at 14–34 weeks with leg cramps at least twice weekly; 80 completed
FormMagnesium bisglycinate chelate
Dose300 mg elemental magnesium daily. The study gave 100 mg three times daily.
Dose basis300 mg elemental magnesium daily. The study gave 100 mg three times daily.
ComparatorPlacebo
DurationFour weeks
Confidence1/4: Risk of bias: There were dropouts; counts and percentages from the abstract require reconciliation with the full text.; Consistency: According to a Cochrane review, pregnancy cramp trials produced conflicting results.; Applicability to the specified group: The data apply directly to pregnant people with the specified symptoms, not other groups. There is no additional reduction in confidence on this basis.; Precision: One small study; precision and safety data are limited.; Possible publication bias: No specific publication bias has been established. There is no additional reduction in confidence on this basis.
Evidence base2 publications described
Sources[2] [3]

More details

How to apply the results to yourself

The results apply to the described groups with frequent leg cramps. During pregnancy, discuss supplement choice and amount with a professional. [2] [3]

Sources

  1. Secondary prevention of leg cramps using compression stockings or magnesium supplements: a three-arm randomized clinical trial. https://doi.org/10.1186/s13063-025-09370-z
  2. Oral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial. https://pubmed.ncbi.nlm.nih.gov/22909270/
  3. Interventions for leg cramps during pregnancy | Cochrane. https://www.cochrane.org/evidence/CD010655_interventions-leg-cramps-during-pregnancy

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Magnesium